258 related articles for article (PubMed ID: 15106184)
61. Treatment for cryoglobulinemic and non-cryoglobulinemic peripheral neuropathy associated with hepatitis C virus infection.
Benstead TJ; Chalk CH; Parks NE
Cochrane Database Syst Rev; 2014 Dec; (12):CD010404. PubMed ID: 25525951
[TBL] [Abstract][Full Text] [Related]
62. Medicinal herbs for hepatitis C virus infection.
Liu JP; Manheimer E; Tsutani K; Gluud C
Cochrane Database Syst Rev; 2001; 2001(4):CD003183. PubMed ID: 11687177
[TBL] [Abstract][Full Text] [Related]
63. Pegylated interferon-α2a and ribavirin versus pegylated interferon-α2b and ribavirin in chronic hepatitis C : a meta-analysis.
Flori N; Funakoshi N; Duny Y; Valats JC; Bismuth M; Christophorou D; Daurès JP; Blanc P
Drugs; 2013 Mar; 73(3):263-77. PubMed ID: 23436591
[TBL] [Abstract][Full Text] [Related]
64. Pharmacotherapies that specifically target ammonia for the prevention and treatment of hepatic encephalopathy in adults with cirrhosis.
Zacharias HD; Zacharias AP; Gluud LL; Morgan MY
Cochrane Database Syst Rev; 2019 Jun; 6(6):CD012334. PubMed ID: 31204790
[TBL] [Abstract][Full Text] [Related]
65. [Glucocorticosteroids for people with alcoholic hepatitis (Cochrane review)].
Pavlov CS; Varganova DL; Casazza G; Tsochatzis E; Nikolova D; Gluud C
Ter Arkh; 2019 Aug; 91(8):52-66. PubMed ID: 32598755
[TBL] [Abstract][Full Text] [Related]
66. Immunoglobulins, vaccines or interferon for preventing cytomegalovirus disease in solid organ transplant recipients.
Hodson EM; Jones CA; Strippoli GF; Webster AC; Craig JC
Cochrane Database Syst Rev; 2007 Apr; (2):CD005129. PubMed ID: 17443573
[TBL] [Abstract][Full Text] [Related]
67. Glucocorticosteroids for primary sclerosing cholangitis.
Chen W; Gluud C
Cochrane Database Syst Rev; 2004; (3):CD004036. PubMed ID: 15266513
[TBL] [Abstract][Full Text] [Related]
68. Antiviral therapy for recurrent liver graft infection with hepatitis C virus.
Gurusamy KS; Osmani B; Xirouchakis E; Burroughs AK; Davidson BR
Cochrane Database Syst Rev; 2009 Jan; (1):CD006803. PubMed ID: 19160303
[TBL] [Abstract][Full Text] [Related]
69. Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma: serious adverse events.
O'Shea O; Stovold E; Cates CJ
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD007694. PubMed ID: 33852162
[TBL] [Abstract][Full Text] [Related]
70. Meta-analysis: ribavirin plus interferon vs. interferon monotherapy for chronic hepatitic C - an updated Cochrane review.
Brok J; Gluud LL; Gluud C
Aliment Pharmacol Ther; 2010 Oct; 32(7):840-50. PubMed ID: 20839385
[TBL] [Abstract][Full Text] [Related]
71. Antiplatelet agents for the treatment of deep venous thrombosis.
Flumignan CD; Nakano LC; Baptista-Silva JC; Flumignan RL
Cochrane Database Syst Rev; 2022 Jul; 7(7):CD012369. PubMed ID: 35876829
[TBL] [Abstract][Full Text] [Related]
72. Antibody induction versus placebo, no induction, or another type of antibody induction for liver transplant recipients.
Penninga L; Wettergren A; Wilson CH; Chan AW; Steinbrüchel DA; Gluud C
Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD010253. PubMed ID: 24901467
[TBL] [Abstract][Full Text] [Related]
73. Nutrition support in hospitalised adults at nutritional risk.
Feinberg J; Nielsen EE; Korang SK; Halberg Engell K; Nielsen MS; Zhang K; Didriksen M; Lund L; Lindahl N; Hallum S; Liang N; Xiong W; Yang X; Brunsgaard P; Garioud A; Safi S; Lindschou J; Kondrup J; Gluud C; Jakobsen JC
Cochrane Database Syst Rev; 2017 May; 5(5):CD011598. PubMed ID: 28524930
[TBL] [Abstract][Full Text] [Related]
74. Hepatitis B vaccination for patients with chronic renal failure.
Schroth RJ; Hitchon CA; Uhanova J; Noreddin A; Taback SP; Moffatt ME; Zacharias JM
Cochrane Database Syst Rev; 2004; 2004(3):CD003775. PubMed ID: 15266500
[TBL] [Abstract][Full Text] [Related]
75. Systemic treatments for metastatic cutaneous melanoma.
Pasquali S; Hadjinicolaou AV; Chiarion Sileni V; Rossi CR; Mocellin S
Cochrane Database Syst Rev; 2018 Feb; 2(2):CD011123. PubMed ID: 29405038
[TBL] [Abstract][Full Text] [Related]
76. Nutritional support for liver disease.
Koretz RL; Avenell A; Lipman TO
Cochrane Database Syst Rev; 2012 May; 2012(5):CD008344. PubMed ID: 22592729
[TBL] [Abstract][Full Text] [Related]
77. Antiviral prophylactic intervention for chronic hepatitis C virus in patients undergoing liver transplantation.
Gurusamy KS; Tsochatzis E; Davidson BR; Burroughs AK
Cochrane Database Syst Rev; 2010 Dec; (12):CD006573. PubMed ID: 21154370
[TBL] [Abstract][Full Text] [Related]
78. Lamivudine or adefovir dipivoxil alone or combined with immunoglobulin for preventing hepatitis B recurrence after liver transplantation.
Katz LH; Tur-Kaspa R; Guy DG; Paul M
Cochrane Database Syst Rev; 2010 Jul; (7):CD006005. PubMed ID: 20614442
[TBL] [Abstract][Full Text] [Related]
79. Flumazenil versus placebo or no intervention for people with cirrhosis and hepatic encephalopathy.
Goh ET; Andersen ML; Morgan MY; Gluud LL
Cochrane Database Syst Rev; 2017 Jul; 7(7):CD002798. PubMed ID: 28745801
[TBL] [Abstract][Full Text] [Related]
80. Ribavirin monotherapy for chronic hepatitis C infection: a Cochrane Hepato-Biliary Group systematic review and meta-analysis of randomized trials.
Brok J; Gluud LL; Gluud C
Am J Gastroenterol; 2006 Apr; 101(4):842-7. PubMed ID: 16494584
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
